Article

Eosinophil cationic protein and histamine after intestinal challenge in patients with cow's milk intolerance

University of Gothenburg, Goeteborg, Västra Götaland, Sweden
Journal of Allergy and Clinical Immunology (Impact Factor: 11.25). 09/1997; 100(2):216-21. DOI: 10.1016/S0091-6749(97)70227-6
Source: PubMed

ABSTRACT Mast cells and eosinophils are key cells in the development of active symptoms in allergic diseases and other inflammatory conditions, and they mediate their action through the release of very potent granule constituents.
Five patients with milk-related gastrointestinal symptoms diagnosed by double-blind placebo-controlled milk challenges, but with negative responses to skin prick tests and RASTs with milk, and eight healthy control subjects were investigated. Repeated perfusion studies were performed with a two-balloon, six-channel tube by using milk, casein, and whey as antigens. Luminal eosinophil cationic protein, histamine, and albumin were measured by radioimmunoassay.
Luminal cow's milk induced a pronounced increase in intestinal secretion of histamine and eosinophil cationic protein in patients, but not control subjects, during the first 20 minutes after challenge (histamine from 123 +/- 12 to 543 +/- 175 ng/cm, hr; eosinophil cationic protein from 80 +/- 23 to 686 +/- 262 ng/cm, hr). Albumin, as a marker of plasma leakage, was also significantly increased.
These data indicate that mast cells and eosinophils are effector cells not only in patients with allergic disease but also in patients intolerant to foods and lacking circulating antibodies. The underlying mechanisms may be a reaction mediated by locally appearing antibodies or an immunologic activation resembling that found in intestinal disorders such as celiac disease.

0 Followers
 · 
81 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: During evolution, the mucosal immune system has developed two homeostatic mechanisms: (i) immune exclusion mediated by secretory antibodies to control epithelial colonization of microorganisms and inhibit penetration of potentially dangerous substances; and (ii) immunosuppression to counteract hypersensitivity against innocuous antigens such as allergens and most food proteins. The latter mechanism is referred to as ‘oral tolerance’ when induced via the gut. Similar down-regulatory mechanisms apparently operate against components of the commensal microbiota. This two-layered anti-inflammatory preservation of mucosal integrity probably explains why overt and persistent allergy to dietary proteins is not more common, with the exception of gluten-intolerance (coeliac disease), where abrogation of mucosal homeostasis becomes apparent. Overall, mucosally induced oral tolerance is a robust adaptive mechanism in view of the fact that a ton of food may pass annually through the gut of an adult ? regularly resulting in uptake of some intact dietary antigens. However, the immunoregulatory network and the epithelial barrier function are poorly developed for a variable period after birth. The neonatal period is therefore critical with regard to priming for allergy. Notably, the postnatal development of mucosal immune homeostasis depends on appropriate microbial colonization. In this process, dendritic antigen-presenting cells are ‘decision makers’ ? linking innate and adaptive immunity; their function is influenced by both microbial products and dietary constituents, including vitamin A and lipids such as polyunsaturated -3 fatty acids.
    12/2008: pages 529-561;
  • [Show abstract] [Hide abstract]
    ABSTRACT: The association between increased tissue eosinophilia and allergic disease is particularly striking in the case of the gastrointestinal tract. About 80% of individuals with eosinophilic gastrointestinal disorders (EGIDs) are atopic, while half of the patients with gastrointestinal allergy show tissue eosinophilia. The function of eosinophils in gastrointestinal allergic disorders is unclear; however, a proinflammatory action is most likely. Cytokines (interleukins 5 and 3, granulocyte-monocyte colony-stimulating factor) and chemokines (eotaxin, RANTES, etc.) released by Th2 lymphocytes, mast cells and other tissue cells have been identified as major regulators of eosinophil chemotaxis and activation, but a convincing mechanism by which eosinophils are activated in an allergen-dependent manner is still lacking. The diagnostic approach comprises both histological and laboratory methods to assess eosinophilia and eosinophil activation, as well as tools to assess the allergic disease while excluding other gastrointestinal diseases such as food intolerances, infections and tumours. Treatment of allergic EGIDs includes elimination or elemental diets and drug therapy using classical anti-allergic agents such as topical corticosteroids and new approaches such as LTD4 receptor antagonists or antibodies against IL-5 or eotaxin.
    Baillière&#x027 s Best Practice and Research in Clinical Gastroenterology 02/2008; 22(3):455-79. DOI:10.1016/j.bpg.2007.11.010 · 3.28 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Seven infants aged 2 to 6 months presented with vomiting, diarrhea, apathy, and shocklike state up to 2 hours after ingesting 100 to 200 mL of soy-based formula. The reasons for the administration of soy-based formula were atopic family history, atopic dermatitis, constipation, acute gastroenteritis, and Jewish dietary (Kashrut) laws; in only one patient was soy-based formula given because of cow milk allergy. Three of the patients had a similar reaction on repeated inadvertent exposure to soy-based formula. Five infants tolerated humanized milk formula without any adverse events. In one infant an allergic reaction to humanized milk formula (generalized urticaria and vomiting) developed at age 8 months, up to which time he had been exclusively breast fed. Only one infant had a positive skin test to soybean. The two cow milk-allergic infants had a positive skin test to cow milk. Five infants underwent oral soybean challenges at age 12 to 24 months, all of which were negative. We conclude that soybean allergy may appear in cow milk-tolerant infants in the first months of life. These infants, including the two infants with IgE-mediated cow milk allergy, presented with gastrointestinal symptoms only, which is compatible with food-induced enterocolitis.
    Pediatric Asthma Allergy &amp Immunology 12/1998; 12(4):253-258. DOI:10.1089/pai.1998.12.253